Ghislaine Cherel

Title: Ghislaine Cherel: Innovator in Blood Coagulation Research

Introduction

Ghislaine Cherel is a notable inventor based in Le Kremlin-Bicetre, France. She has made significant contributions to the field of blood coagulation disorders through her innovative research and patented inventions. With a total of 3 patents, her work focuses on the development of serine protease derivatives that have potential therapeutic applications.

Latest Patents

Ghislaine Cherel's latest patents include groundbreaking inventions related to serine protease derivatives. One of her notable patents is titled "Serene protease derivatives and uses in the prevention or the treatment of blood coagulation disorders." This invention involves chimeric derivatives of serine protease zymogen that contain the activation peptide of factor X or a fragment thereof. The aim is to improve the half-life of these derivatives, which are primarily protein C and factor X derivatives. The invention also addresses their use in preventing or treating blood coagulation disorders.

Career Highlights

Ghislaine Cherel is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she conducts her research. Her work has been instrumental in advancing the understanding and treatment of blood coagulation disorders.

Collaborations

Ghislaine collaborates with esteemed colleagues, including Olivier Christophe and Cecile Denis, who contribute to her research endeavors.

Conclusion

Ghislaine Cherel's innovative work in the field of blood coagulation research highlights her dedication to improving medical treatments. Her patents reflect her commitment to advancing science and healthcare.